6533b851fe1ef96bd12a95e2

RESEARCH PRODUCT

Muscleblind-like 1 regulates epithelial to mesenchymal transition markers in triple-negative breast cancer

I. Garrido-canoB. PattanayakPilar ErolesA. Adam ArtiguesEduardo TormoEstefanía Cerro-herrerosB. Pineda MerloP. CabelloM. SabaterRuben Artero

subject

Oncologybusiness.industryCancer researchMedicineHematologyEpithelial–mesenchymal transitionbusinessTriple-negative breast cancerhttps://doi.org/10.1093/annonc/mdy314.041